MedTrace Logo

Permission to Collect Blood Over Time for Research

NCT00767234 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2016-07-11

No results posted yet for this study

Summary

To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study is to identify key biomarkers derived from blood that are most characteristic and informative of individuals who will go on to develop a clotting complication.

Conditions

  • Pancreatic Cancer
  • Gastrointestinal Neoplasms
  • Colon Rectal Cancer Adenocarcinoma
  • Esophageal Cancer
  • Gall Bladder Cancer
  • Gastric (Stomach) Cancer
  • Gastrooesophageal Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Hepatobiliary Neoplasm
  • Liver Carcinoma
  • Gallbladder Carcinoma
  • Bile Duct Carcinoma
  • Carcinoma of the Large Intestine
  • Anal Cancer

Interventions

PROCEDURE

Observation

Standard of Care

Sponsors & Collaborators

Principal Investigators

  • Haruka Itakura · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767234 on ClinicalTrials.gov